دورية أكاديمية
S126: GEMTUZUMAB‐BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL.
| العنوان: | S126: GEMTUZUMAB‐BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL. |
|---|---|
| المؤلفون: | Russell, N., Wilhelm‐Benartzi, C., Othman, J., Dillon, R., Potter, N., Jovanovic, J., Gilkes, A., Batten, L. M., Canham, J., Hinson, E. L., Kottaridis, P., Cavenagh, J., Arnold, C., Dennis, M., Knapper, S. |
| المصدر: | HemaSphere; 2022 Supplement 3, Vol. 6, p27-28, 2p |
| قاعدة البيانات: | Complementary Index |
Full Text Finder | تدمد: | 25729241 |
|---|---|
| DOI: | 10.1097/01.HS9.0000843396.14484.b9 |